How to Verify the Pharmacy Behind a GLP-1 Program

To check the pharmacy behind a GLP-1 program, obtain its exact name, address and license information, then verify the relevant state board record. If it claims to be a 503B outsourcing facility, check FDA's register separately. A telehealth brand's certification does not establish that every product it sells is FDA approved.

A telehealth seller, a prescribing practice and a dispensing pharmacy can be different businesses. You may encounter all three during enrollment. A clear program explains which does what and identifies the pharmacy handling your prescription. This guide concerns that verification process, rather than declaring any particular compounded product safe.

Which company's identity should you ask for?

Ask for the pharmacy that will actually dispense the medication, not only a list of possible partners. Request the legal name, physical address, telephone number and license details. If the company cannot assign a pharmacy until a clinician approves treatment, ask when that information becomes available and whether you can review it before a nonrefundable charge.

Keep the answer with the prescription and invoice. A customer service brand name may differ from the legal name on a license. That does not automatically indicate a problem, but you need enough information to reconcile the records. Ask the program to explain a mismatch rather than guessing that similar names identify the same business.

The question is especially useful before a refill. A program can change pharmacies, so the information from an earlier shipment may not describe the next one. Ask whether the new label or instructions will differ if the dispensing arrangement changes.

How do you check a state pharmacy license?

FDA's BeSafeRx page links to state board pharmacy-license databases. FDA recommends confirming the pharmacy's license and checking that it requires a prescription, has U.S. contact details and makes a licensed pharmacist available.¹ Use the official board record rather than a search-result snippet or a badge supplied by the merchant.

Search the exact legal name and location. If there are several matches, compare the address and license number. Look at the current status and the type of license shown. If you do not understand whether the record covers dispensing to your state, ask the relevant board or pharmacy to explain the authorization.

Keep the date and the record you checked. License status and business arrangements can change. A screenshot without a date or a third-party directory entry can be a useful lead, but it should not be presented as current official confirmation.

Do not treat an NPI listing, corporate registration or domain ownership record as a pharmacy license. Those records answer different questions. The evidence should match the claim being made: dispensing authority needs the appropriate pharmacy regulatory record.

What do 503A and 503B mean?

These terms refer to different federal compounding pathways. They do not identify an FDA-approved finished GLP-1 product. FDA explains that the conditions for compounding under each pathway differ, including requirements related to patient-specific prescriptions, copies of commercially available medicines and use of bulk substances.²

For a program describing a pharmacy as 503A, ask which state licenses apply and how the actual prescription is handled. For a claimed 503B outsourcing facility, use FDA's registered-outsourcing-facility page to check the exact facility. Registration is a separate fact from approval of the drug you receive.³

Avoid a blanket conclusion that either label proves every prescription is lawful or that the product is equivalent to an approved brand. The pharmacy's status, the product and the circumstances of compounding are different questions. Our compounding safety and legitimacy overview explains the broader regulatory context.

What should you look for in FDA's 503B records?

Start with the exact facility name and location. FDA's register includes facility information and may link to inspection or compliance documents. Match the site rather than assuming a brand's parent company or another address is the facility involved.³

Read documents in context. An inspection observation, a warning letter and an enforcement outcome are different records. Note the dates and the actual product or practice discussed. Do not turn a historical observation into an unsupported claim that a business is currently closed, or interpret the absence of a letter as a guarantee of quality.

If a program uses the phrase FDA registered, ask what entity is registered and under which program. A registration claim should point to a verifiable record. It should not be allowed to imply approval of a compounded GLP-1 that has not undergone the approval process.

Does LegitScript certification verify the pharmacy?

Certification can concern a particular business or website, while the prescription may be filled by another entity. Ask which domain and organization the certification covers. Even a genuine certification does not answer every question about the dispensing pharmacy, prescription or product.

For the pharmacy itself, use the official license record and the relevant FDA register when a 503B claim is made. For the medicine, ask whether it is an approved branded product or a compounded prescription and which instructions apply. These checks complement one another; a single logo should not replace them.

A certification claim needs its own confirmation. Check the exact business name and scope in the relevant public record, and keep an unconfirmed claim separate from an established license or registration.

What can the prescription label help you verify?

When the package arrives, compare the label with the information you were given. Confirm the dispensing pharmacy, patient, medicine, concentration, directions and relevant dates. If anything is missing or unfamiliar, contact the pharmacist before using it. Do not assume a new concentration uses the same syringe markings as an old one.

FDA has warned about fraudulent compounded GLP-1 products, including labels naming pharmacies that did not make the product or that do not exist. A printed pharmacy name therefore needs confirmation, particularly if the packaging or source raises concerns.⁴

Use an independently verified contact number when reconciling a suspicious label. Explain the prescription details and ask whether the pharmacy dispensed it. Keep the packaging and payment record. A seller's reassurance alone is not the same as confirmation from the named pharmacy.

What if the medication arrives warm or the instructions conflict?

Contact the dispensing pharmacist and the telehealth clinical team with the product details and shipment history. Ask whether the medicine remains usable under the instructions that apply to that exact preparation. Do not apply a branded pen's storage window to an unidentified compounded vial.

The storage guide covers product-specific storage questions. The units-to-mg guide explains why concentration matters. Neither should be used to make an unfamiliar product fit instructions written for a different preparation.

If the pharmacy's directions and the prescriber's directions differ, ask them to reconcile the prescription. Keep the written resolution. Do not average the numbers, reuse an old syringe chart or select the instruction that seems easiest.

What counts as a useful answer before payment?

A useful response identifies the responsible entity, gives you a way to verify it and explains what is still undecided. A statement such as we use licensed pharmacies is less useful than the name and record of the pharmacy that will fill your order. If the program cannot yet assign it, a clear policy explains the next step.

Ask how you can contact a pharmacist, how dispensing questions are escalated and what happens if the order cannot be fulfilled. Check the billing and cancellation terms separately. Transparency about sourcing does not resolve a contract question, and a flexible contract does not establish medication quality.

How should this affect your shortlist?

Compare documented pharmacy identity alongside clinical access, price and program flexibility. Keep unknown information labeled as unknown. If a pharmacy or program will not resolve a material discrepancy, discuss another route with your clinician rather than treating a low price as an answer.

The provider selection checklist covers the full comparison, and compounded versus brand-name medication explains the product distinction. The goal of verification is a traceable prescription and a clear contact for questions, with each claim supported by the record that actually establishes it.

An example: the pharmacy on the vial has changed

Suppose a refill arrives from a different pharmacy than the one named at enrollment. Ask the program whether this was an intended change and verify the new dispenser's record. Compare the concentration and directions with the current prescription. Do not assume an earlier dosing diagram applies simply because the seller and molecule are unchanged.

If the new pharmacy confirms the prescription, ask it to explain any changed preparation or storage instructions. If it does not recognize the product, keep the packaging and contact the prescriber before use. Record which organization answered and what it confirmed. This gives you a clearer basis for the next step than treating every changed label as either harmless or fraudulent without checking.